Skip to main content
logo
Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.03
-0.01 (-0.20%)
Jul 22, 2026, 9:45 AM HKT

Jiangsu Recbio Technology Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
12.7312.73-30.385.336.2
Revenue Growth
-56.29%--470.46%-14.10%325.17%
Gross Profit
9.249.24-11.0622.345.336.2
Operating Income
-604.41-604.41-598.85-617.75-875.08-613.26
Net Income
-610.39-610.39-557.46-571.96-722.7-657.56
Earnings Per Share
-1.15-1.15-1.16-1.19-1.52-1.56
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
356.19356.19450.35837.761,3291,186
Total Debt
638.47638.47889.1650.8282.6376.72
Net Cash (Debt)
-282.28-282.28-438.75186.971,0461,109
Net Cash Growth
----82.13%-5.63%68.29%
Net Cash Per Share
-0.53-0.53-0.920.392.212.63

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-502.64-502.64-464.83-638.07-579.54-472.92
Capital Expenditures
-98.86-98.86-171.83-212.04-296.73-237.87
Free Cash Flow
-601.5-601.5-636.66-850.11-876.27-710.79
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
72.61%72.61%-73.54%100.00%100.00%
Operating Margin
-4749.39%-4749.39%--2033.60%-16433.33%-9892.89%
Pretax Margin
-4779.43%-4779.43%--1884.46%-13821.52%-10607.61%
Profit Margin
-4796.40%-4796.40%--1882.86%-13571.89%-10607.53%
FCF Margin
-4726.54%-4726.54%--2798.55%-16455.78%-11466.17%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
219.08174.22-155.871973.60-